Regencell Bioscience Holdings Ltd

RGCNASDAQ · USD
6.17USD0.00 (0.00%)
112

Regencell Bioscience Holdings Ltd (RGC) Covered Calls

As of September 25, 2026, RGC has 3 covered call opportunities in the coming three months. Return ranges from 25.6 to 63.7% until expiration. Annualized return ranges from 273.2 to 1,107.1%. The nearest expiration is October 16, 2026. Maximum potential profit is $393.

Read more

Running RGC covered calls helps you generate consistent income from Regencell Bioscience Holdings Ltd's shares you already own, turning a long stock position into a yield-producing asset. A covered call on Regencell Bioscience Holdings Ltd involves holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike price. Use our scanner to find the best RGC covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.

A covered call is one of the most widely used options strategies because it pairs limited risk with a clear income profile: if RGC stays below the strike at expiration, you keep the premium and the shares; if it rises above, you deliver the stock at the strike and still pocket the premium. Selling RGC covered calls works best when implied volatility is elevated, since richer premiums improve the risk-reward. Key inputs to evaluate include strike selection relative to delta, days to expiration, annualized return, and the probability of assignment — all of which determine whether a given Regencell Bioscience Holdings Ltd covered call is worth writing.

Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.

Income-focused investors, long-term RGC holders, and systematic premium sellers all face the same challenge: finding the covered call strike and expiry that balances yield against the risk of being called away. Our scanner ranks covered calls by annualized return, downside protection, and probability of profit, so selling RGC covered calls becomes a measured decision instead of a guess. Stop eyeballing the chain — let the best Regencell Bioscience Holdings Ltd covered calls come to you, already filtered for the metrics that matter.

Stock Statistics

  • IndustryDrug Manufacturers - Specialty & Generic
  • SectorHealthcare
  • IV percentile82.14% Elevated
  • Market cap (M$)3,057
  • 52 weeks high-91.06%
  • 52 weeks low36.81%
  • Analyst recommendation—
  • Target price—
  • Dividend—
  • Payout ratio—
  • Earnings date2026-10-28
  • P/E—
  • Future P/E—
  • EPS (ttm)-0.01
  • EPS growth next 5 years—

As of September 25, 2026

2026-10-162110.0062.070.101.00393.0063.701107.08-1.62+0.31150.90
2026-10-16217.5021.560.250.50158.0025.61445.09-4.05+0.332060.25
2026-12-188410.0062.070.053.00388.0062.88273.25-0.81+0.51802.95

As of September 25, 2026

Sell covered calls with the data behind you

Find the best RGC covered call setups ranked by annualized return, filter by premium, delta, and days to expiration, and act on the opportunity in seconds.

Start your 14-day free trial